Skip main navigation

Military Health System

Clear Your Browser Cache

This website has recently undergone changes. Users finding unexpected concerns may care to clear their browser's cache to ensure a seamless experience.

Skip subpage navigation

Respiratory Syncytial Virus

RSV Vaccine Resource Center

RSVRespiratory syncytial virus is a common respiratory virus that usually causes mild, cold-like symptoms. RSV can also cause more severe infections such as bronchiolitis and pneumonia. The population at highest risk for severe RSV includes infants and young children, especially premature infants and those with chronic/congenital health issues. Older adults with heart or lung disease or weakened immune systems are also at higher risk.

RSV is transmitted through contact with droplets from the nose and throat when an infected person coughs or sneezes. It can also spread through contact with respiratory secretions on bedclothes, doorknobs and similar items and then touching the eyes, nose, or mouth. RSV can remain on hard surfaces for many hours and on soft surfaces for shorter amounts of time. Transmission can occur 1 to 2 days prior to symptoms until about 8 days after showing signs of illness. Some infants and immunocompromised individuals can spread the virus even after symptoms resolve, up to 4 weeks.

In May 2023, the FDA approved two separate vaccines by different manufacturers for RSV. They are indicated for active immunization for the prevention of lower respiratory tract disease caused by respiratory syncytial virus. The Advisory Committee on Immunization Practices recommended that individuals 60 years of age and older may receive a single dose of an RSV vaccine, using shared clinical decision-making. RSV vaccine is also recommended for pregnant people between 32 and 36 weeks gestation to protect their newborn from severe RSV illness. Each vaccination is 0.5mL administered intramuscularly.

Resource Center

You will find below all of the resources you will need about the RSV vaccine. More will be added as they are published or released.

Information Paper Date
Respiratory Syncytial Virus Disease and RSV Vaccine Feb. 8, 2024
Standing Orders Date
RSV Vaccine (Adult)
July 2, 2024
Respiratory Syncytial Virus Vaccine (Abrysvo) During Pregnancy
Dec. 22, 2023 
Vaccine Information Statements Date
Respiratory Syncytial Virus Vaccine: What You Need to Know July 24, 2023
Manufacturer Package Inserts Date
ABRYSVO Aug. 21, 2023
AREXVY May 23, 2023
Advisory Committee on Immunization Practices Recommendations Date
Respiratory Syncytial Virus Vaccines
Oct. 13, 2023
Last Updated: July 18, 2024
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Sign up on GovDelivery